Viewing Study NCT03775018

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:05 AM

Ignite Modification Date: 2025-12-26 @ 4:08 AM

Study NCT ID: NCT03775018

Status: UNKNOWN

Last Update Posted: 2018-12-13

First Post: 2018-12-12

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: TAP Blockade for Pain Control in One-Anastomosis Gastric Bypass

Sponsor: Hospital General Universitario Elche

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Overview

Official Title: Transversus Abdominis Plane (TAP) Blockade as Multimodal Analgesia for Pain Control in One-Anastomosis Gastric Bypass (OAGB)

Status: UNKNOWN

Status Verified Date: 2018-12

Last Known Status: NOT_YET_RECRUITING

Delayed Posting: No

If Stopped, Why?: Not Stopped

Has Expanded Access: False

If Expanded Access, NCT#: N/A

Has Expanded Access, NCT# Status: N/A

Acronym: None

Brief Summary: Patients will be randomized into 2 groups:

* TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia
* IV: Patients receiving only intravenous Acetaminophen analgesia

Postoperative pain 24 hours after surgery will be evaluated.

Detailed Description: Patients will be randomized into 2 groups:

* TAP: Patients undergoing TAP blockade, associated with intravenous Acetaminophen analgesia (1g/6h)
* IV: Patients receiving only intravenous Acetaminophen analgesia (1g/6h)

Postoperative pain 24 hours after surgery will be evaluated, by a Visual Analogic Scale (VAS), ranging from 0 to 100mm.

Study Oversight

Has Oversight DMC: True

Is a FDA Regulated Drug?: False

Is a FDA Regulated Device?: False

Is an Unapproved Device?: None

Is a PPSD?: None

Is a US Export?: None

Is an FDA AA801 Violation?: